Fluorouracil: all 820 studies that test it
Page 5 of 9. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.CompletedNCT02834559Phase 3
- Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck CancerTerminatedNCT02817113Phase 1
- Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal CancerWithdrawnNCT02785068Phase 1/2
- Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After ResectionStatus unknownNCT02767375Phase 2/3
- The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy SurgeryCompletedNCT02767219Phase 3
- Curcumin in Combination With 5FU for Colon CancerTerminatedNCT02724202Early Phase 1
- Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)CompletedNCT02710734Phase 2
- Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal CancerStatus unknownNCT02688023Phase 2
- Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and CapecitabineCompletedNCT02648425Phase 1
- Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal CancerWithdrawnNCT02573220Phase 1
- Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal CancerActive, not recruitingNCT02560298Phase 2
- Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACEStatus unknownNCT02557503Phase 4
- A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell CarcinomaCompletedNCT02550678Phase 1/2
- A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaCompletedNCT02539537Phase 3
- Strategies for Management of Recurrent PterygiumStatus unknownNCT02530801Phase 4
- Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma PatientsStatus unknownNCT02523053Not applicable
- Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the EsophagusActive, not recruitingNCT02509286Phase 3
- Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative ResectionStatus unknownNCT02506842Phase 3
- Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) TherapyCompletedNCT02484677Phase 4
- A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal CancerCompletedNCT02459457Phase 3
- Adjuvant FEC Versus EP in Breast Cancer (MIG5)CompletedNCT02450058Phase 3
- RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCCStatus unknownNCT02426450Phase 2
- Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal CarcinomaCompletedNCT02402842Phase 2
- Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast CancerCompletedNCT02365805Phase 2
- Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal CancerCompletedNCT02353858Phase 2
- Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver MetastasisWithdrawnNCT02345746Phase 2
- Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT02333188Phase 1
- Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal CancerStatus unknownNCT02325986Phase 2
- Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic MarkersWithdrawnNCT02296671Phase 2
- Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic KeratosesCompletedNCT02289768Phase 3
- Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric CancerStatus unknownNCT02289378Phase 2
- Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal CancerCompletedNCT02284529Phase 4
- IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic KeratosisStatus unknownNCT02281682Phase 4
- RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).Status unknownNCT02280070Phase 2
- Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal CancerCompletedNCT02270606Phase 1
- Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic KeratosisCompletedNCT02242747Not applicable
- Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal CancerWithdrawnNCT02235324Phase 2
- CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT02232152Phase 1
- Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric CancerStatus unknownNCT02229045Phase 2
- Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas CarcinomaCompletedNCT02172976Phase 2/3
- Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot StudyCompletedNCT02155439Phase 4
- The Study of Laparoscopic-assisted Percutaneous Catheter-directed Drainage to Treat Early Severe Acute PancreatitisStatus unknownNCT02133014Not applicable
- Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric CancerCompletedNCT02114359Phase 3
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable PatientsStatus unknownNCT02099188Phase 2
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable PatientsStatus unknownNCT02099175Phase 2
- Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to OxaliplatinStatus unknownNCT02087475Phase 3
- Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal CancerStatus unknownNCT02071069Phase 2
- Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCCCompletedNCT02047201Phase 2
- Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal CancerWithdrawnNCT02046538Phase 2
- A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the EsophagusTerminatedNCT02017600Phase 2
- Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and NeckTerminatedNCT02015650Phase 4
- Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative ManagementActive, not recruitingNCT02008656Phase 2
- Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast CancerCompletedNCT02001506Phase 3
- Borderline Pancreas Study: FOLFIRINOX +SBRTCompletedNCT01992705Early Phase 1
- Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast CancerTerminatedNCT01985841Phase 2
- Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal CancerStatus unknownNCT01972503Phase 4
- The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular CarcinomaWithdrawnNCT01953406Phase 2
- Metformin and 5-fluorouracil for Refractory Colorectal Cancer.CompletedNCT01941953Phase 2
- A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid MalignanciesCompletedNCT01930552Phase 1
- Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT01926236Phase 3
- Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell CancerCompletedNCT01914900Phase 2
- A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)CompletedNCT01911598Phase 1
- Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal CancerCompletedNCT01740648Phase 1
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)CompletedNCT01726452Phase 3
- Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal CancerTerminatedNCT01715363Phase 2
- Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid TumorsCompletedNCT01653470Phase 1
- Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesCompletedNCT01643499Phase 1
- Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the StomachCompletedNCT01640782Phase 3
- Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRCWithdrawnNCT01631539Not applicable
- Second Look Laparoscopy in Colorectal CancerStatus unknownNCT01628211Phase 2
- Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0CompletedNCT01621217Phase 1
- Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal CancerTerminatedNCT01613469Phase 2
- A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal CarcinomaCompletedNCT01591135Phase 3
- A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas CancerStatus unknownNCT01586611Phase 3
- Study of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasCompletedNCT01572324Phase 2
- Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric CancerCompletedNCT01567618Phase 2
- Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT01561014Phase 1
- Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerStatus unknownNCT01529164Phase 2
- PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor MalignanciesStatus unknownNCT01522989Phase 1
- Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
- Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent EpendymomaCompletedNCT01498783Phase 1
- Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract CancerStatus unknownNCT01494363Phase 2
- LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic CancerCompletedNCT01485744Phase 1
- Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachCompletedNCT01472029Phase 2
- Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck CancerCompletedNCT01467115Phase 2
- Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas CancerStatus unknownNCT01411072Not applicable
- 5fluorouracil for Advanced PhotoagingStatus unknownNCT01405144Phase 3
- Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable TumoursCompletedNCT01397019Phase 2
- Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerCompletedNCT01383343Phase 1
- Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal CancerCompletedNCT01376453Phase 1
- S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric CarcinomaCompletedNCT01364376Not applicable
- EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01360827Phase 1
- Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionCompletedNCT01360086Phase 2
- Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and PlaceboCompletedNCT01354717Phase 3
- Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)CompletedNCT01326559Phase 2
- Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon CancerStatus unknownNCT01308086Phase 3
- Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal AdenocarcinomaWithdrawnNCT01302613Phase 1/2
- Keloid Scarring: Treatment and PathophysiologyWithdrawnNCT01295099Phase 4
- Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric AdenocarcinomaCompletedNCT01286766Phase 2
- Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal CancerCompletedNCT01274624Phase 1